How Diazyme’s Kappa & Lambda Free Light Chain Assays Are Improving Diagnostic Confidence – A Testimonial from James DiPhilippo, Laboratory Director at New England Cancer Specialists
30th Apr 2025
Improving Oncology Diagnostics with Diazyme’s Free Light Chain Assays
In the fight against multiple myeloma and related plasma cell disorders, speed and accuracy in diagnostics are essential. For New England Cancer Specialists (NECS), one of the region’s leading oncology practices, bringing free light chain testing in-house was a critical step in improving patient care.
James DiPhilippo (Jim), Laboratory Director at NECS, recently shared how Diazyme’s kappa and lambda free light chain assays enabled his team to streamline operations, improve turnaround time, and deliver higher-quality care.
“A Game Changer for Our Laboratory” – Jim DiPhilippo, NECS
“The Diazyme free light chain assays allowed us to bring this critical test in-house, eliminating the need to send out samples and wait days for results,” said Jim DiPhilippo.
Previously, NECS relied on external reference labs for free light chain testing—a process that added 3–5 days to the turnaround time for a test essential in diagnosing and monitoring multiple myeloma, and other plasma cell dyscrasias. With Diazyme’s assays, NECS was able to perform these tests on-site, accelerating decision-making and reducing patient anxiety.
Why NECS Chose Diazyme’s Free Light Chain Assays
Seamless Integration
Jim highlighted the ease of implementing Diazyme’s assays. The onboarding process was straightforward, with training and support provided by Diazyme’s technical team. This helped NECS staff become proficient quickly—reducing downtime and enabling immediate clinical benefits.
High Performance and Accuracy
Diazyme’s kappa and lambda free light chain assays deliver sensitive, reliable, and reproducible results, aligning with the precision standards required in oncology labs. For NECS, this meant confidence in patient monitoring and diagnostic accuracy.
Rapid Turnaround Time
By eliminating the need to send samples to a reference lab, NECS significantly improved its turnaround time, helping oncologists receive results sooner and begin appropriate treatment without delay.
“Having this test in-house has allowed us to better serve our oncology patients,” Jim said. “The support from Diazyme was excellent—it’s been a great partnership.”
Empowering Laboratories with In-House Testing Capabilities
Diazyme’s commitment to supporting clinical laboratories extends beyond product delivery. Our team partners closely with labs to ensure a smooth transition to in-house testing, providing technical assistance and training throughout the implementation process.
Our free light chain assays are part of a comprehensive portfolio designed to help labs like NECS meet growing diagnostic demands while maintaining efficiency, cost-effectiveness, and clinical excellence.
Ready to Enhance Your Laboratory’s Testing Capabilities?
Discover how Diazyme’s kappa and lambda free light chain assays can transform your diagnostic workflow. Contact us today to learn more about onboarding our assays at your laboratory.
Hear Directly from New England Cancer Specialists
Want to hear more about the real-world impact of our assays?
Watch the full testimonial from Jim DiPhilippo, Laboratory Director at NECS, to learn how Diazyme’s free light chain assays helped their lab improve efficiency and patient care.
Watch the video here (Insert YouTube video)